Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Verrica Pharmaceuticals Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +16 vs. Q3 2025
- Shares held
- 5.20M
- +2.73M (+110.4%) vs. Q3 2025
- Total value
- $43.2M
- +$32.6M (+307.8%) vs. Q3 2025
- New holders
- 22
- 5 more added
- Sold out
- 6
- 10 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $28.5M |
| Q1 2026 | 39 | $25.3M |
| Q4 2025 | 50 | $43.2M |
| Q3 2025 | 34 | $10.6M |
| Q2 2025 | 59 | $13.4M |
| Q1 2025 | 75 | $13.0M |
| Q4 2024 | 81 | $21.0M |
| Q3 2024 | 79 | $21.6M |
| Q2 2024 | 74 | $135.9M |
| Q1 2024 | 62 | $105.1M |
| Q4 2023 | 64 | $131.8M |
| Q3 2023 | 67 | $58.5M |
| Q2 2023 | 63 | $84.2M |
| Q1 2023 | 60 | $84.2M |
| Q4 2022 | 50 | $29.8M |
| Q3 2022 | 49 | $29.9M |
| Q2 2022 | 57 | $21.8M |
| Q1 2022 | 51 | $72.1M |
| Q4 2021 | 45 | $82.0M |
| Q3 2021 | 49 | $114.6M |
| Q2 2021 | 53 | $112.3M |
| Q1 2021 | 51 | $150.4M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Verrica Pharmaceuticals Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,118,925 | $9.30M | 0.23% | +479,732+75.1% | Added |
| Caligan Partners LP | 923,910 | $7.68M | 0.70% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 707,338 | $5.88M | 0.42% | +707,338 | New |
| Velan Capital Investment Management LP | 471,559 | $3.92M | 2.28% | +471,559 | New |
| Stonepine Capital Management, LLC | 353,669 | $2.94M | 2.32% | +353,669 | New |
| Boothbay Fund Management, LLC | 280,734 | $2.33M | 0.06% | 00.0% | Unchanged |
| Kalehua Capital Management LLC | 235,779 | $1.96M | 1.94% | +235,779 | New |
| DAFNA Capital Management LLC | 173,451 | $1.44M | 0.33% | +173,451 | New |
| Vanguard Group Inc | 138,194 | $1.15M | 0.00% | −87,016−38.6% | Reduced |
| Two Sigma Investments, LP | 118,218 | $982.4K | 0.00% | +118,218 | New |
| Jane Street Group, LLC | 101,722 | $845.3K | 0.00% | +101,722 | New |
| Marshall Wace, LLP | 85,173 | $707.8K | 0.00% | +85,173 | New |
| Geode Capital Management, LLC | 67,659 | $562.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 44,430 | $369.2K | 0.00% | +44,430 | New |
| Squarepoint Ops LLC | 33,270 | $276.5K | 0.00% | +33,270 | New |
| Sovran Advisors, LLC | 32,658 | $248.5K | 0.02% | −41,147−55.8% | Reduced |
| Renaissance Technologies LLC | 26,400 | $219.4K | 0.00% | −2,791−9.6% | Reduced |
| Mariner, LLC | 24,544 | $204.0K | 0.00% | −60.0% | Reduced |
| State Street Corp | 23,481 | $195.1K | 0.00% | +2,900+14.1% | Added |
| Millennium Management LLC | 23,123 | $192.2K | 0.00% | −48,867−67.9% | Reduced |
| Omers Administration Corp | 22,600 | $187.8K | 0.00% | +22,600 | New |
| Morgan Stanley | 22,009 | $182.9K | 0.00% | +321+1.5% | Added |
| Northern Trust Corp | 20,024 | $166.4K | 0.00% | −70.0% | Reduced |
| Goldman Sachs Group Inc | 18,621 | $154.7K | 0.00% | +18,621 | New |
| HRT Financial LP | 17,356 | $144.0K | 0.00% | +17,356 | New |
| Legacy Trust | 17,234 | $143.2K | 0.03% | +17,234 | New |
| Walleye Capital LLC | 15,240 | $126.6K | 0.00% | +15,240 | New |
| XTX Topco Ltd | 14,662 | $121.8K | 0.00% | +14,662 | New |
| Bridgeway Capital Management, LLC | 12,000 | $99.7K | 0.00% | 00.0% | Unchanged |
| Beck Mack & Oliver LLC | 12,000 | $99.7K | 0.00% | +12,000 | New |
| Quadrature Capital Ltd | 11,954 | $99.3K | 0.00% | +11,954 | New |
| Man Group plc | 11,287 | $93.8K | 0.00% | +11,287 | New |
| BlackRock, Inc. | 5,685 | $47.2K | 0.00% | −463−7.5% | Reduced |
| Bank of America Corp | 4,343 | $36.1K | 0.00% | +4,271+5,931.9% | Added |
| Tower Research Capital LLC (TRC) | 3,342 | $27.8K | 0.00% | +1,799+116.6% | Added |
| Capital Analysts, LLC | 1,500 | $12.0K | 0.00% | 00.0% | Unchanged |
| Fortitude Family Office, LLC | 608 | $5.05K | 0.00% | +608 | New |
| Royal Bank of Canada | 416 | $3.00K | 0.00% | −793−65.6% | Reduced |
| Salomon & Ludwin, LLC | 290 | $2.57K | 0.00% | 00.0% | Unchanged |
| New England Capital Financial Advisors LLC | 200 | $1.66K | 0.00% | 00.0% | Unchanged |
| International Assets Investment Management, LLC | 175 | $1.45K | 0.00% | +175 | New |
| BNP Paribas Arbitrage, SA | 110 | $914 | 0.00% | −14−11.3% | Reduced |
| The PNC Financial Services Group, Inc. | 102 | $847 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 47 | $391 | 0.00% | +47 | New |
| Optiver Holding B.V. | 31 | $258 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 24 | $199 | 0.00% | −41,608−99.9% | Reduced |
| Group One Trading, L.P. | 3 | $25 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 2 | $17 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $8 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 54 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 0 | $0 | 0.00% | −3,337−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −2,065−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −142−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −568−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −56−100.0% | Sold out |